| Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (NCT07214298) | Roswell Park Cancer Institute | 2026-02-16 |
| A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain (NCT07285018) | Eli Lilly and Company | 2026-02-16 |
| Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma (NCT07302919) | University Hospital, Basel, Switzerland | 2026-02-16 |
| A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases (NCT07041814) | Universiti Kebangsaan Malaysia Medical Centre | 2026-02-15 |
| Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer (NCT07317778) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-02-15 |
| Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases (NCT07382453) | Affiliated Hospital of Nantong University | 2026-02-15 |
| taVNS on Functional Mobility in People With DP (NCT07366411) | Universidade Federal de Pernambuco | 2026-02-15 |
| Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight (NCT07467447) | Hudson Biotech | 2026-02-15 |
| Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients (NCT07400328) | The First Affiliated Hospital of Soochow University | 2026-02-15 |
| Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection (NCT07293910) | Tanta University | 2026-02-15 |
| Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy (NCT07277972) | Tianjin Medical University Cancer Institute and Hospital | 2026-02-15 |
| HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation (NCT07240766) | Zhejiang University | 2026-02-15 |
| Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX (NCT07391826) | The First Affiliated Hospital with Nanjing Medical University | 2026-02-15 |
| Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC (NCT07403435) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-02-15 |
| Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder. (NCT07391878) | Trigone Pharma Ltd. | 2026-02-15 |
| A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplantation (NCT07381114) | Institute of Hematology & Blood Diseases Hospital, China | 2026-02-14 |
| Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma (NCT07545603) | Evopoint Biosciences Inc. | 2026-02-14 |
| Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial (NCT06260891) | University of California, San Francisco | 2026-02-14 |
| ARN-75039 Lassa Fever Treatment in West Africa (NCT07419373) | Arisan Therapeutics, Inc. | 2026-02-14 |
| Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT07470762) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-02-14 |
| Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy (NCT06904911) | University of Pennsylvania | 2026-02-13 |
| CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury (NCT06840899) | University of Wisconsin, Madison | 2026-02-13 |
| Holy Basil in The Treatment of Dyspepsia (NCT07175272) | Mahidol University | 2026-02-13 |
| A Study of Brenipatide in Participants With Opioid Use Disorder (NCT07420283) | Eli Lilly and Company | 2026-02-13 |
| A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH) (NCT07491458) | Rivus Pharmaceuticals, Inc. | 2026-02-13 |
| Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria (NCT07378527) | Beijing InnoCare Pharma Tech Co., Ltd. | 2026-02-13 |
| A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer (NCT07428044) | Memorial Sloan Kettering Cancer Center | 2026-02-13 |
| Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy (NCT07215273) | Elion Therapeutics, Inc. | 2026-02-13 |
| A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy (NCT07210723) | Kardigan, Inc. | 2026-02-13 |
| Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS (NCT07435038) | Betta Pharmaceuticals Co., Ltd. | 2026-02-12 |
| Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma (NCT07449754) | Hanmi Pharmaceutical Company Limited | 2026-02-12 |
| Incretin Microdosing for Cardiometabolic Health in People With HIV (NCT07325500) | The University of Texas Health Science Center, Houston | 2026-02-12 |
| A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE) (NCT07311200) | InventisBio Co., Ltd | 2026-02-12 |
| Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer (NCT07367516) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-02-12 |
| Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (NCT07059091) | Johns Hopkins University | 2026-02-12 |
| Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma (NCT07356245) | Jonathan Brammer | 2026-02-12 |
| Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer (NCT07149363) | Alliance Foundation Trials, LLC. | 2026-02-12 |
| Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells (NCT07042438) | City of Hope Medical Center | 2026-02-11 |
| A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT07363694) | Pfizer | 2026-02-11 |
| Effects of Hemp-Derived Cannabinoids on Menopause Symptoms (NCT07393672) | Washington State University | 2026-02-11 |
| Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs). (NCT07406789) | TNC Nutrición Terapéutica S.L. | 2026-02-11 |
| Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma (NCT06510309) | Gottfried von Keudell, MD PhD | 2026-02-11 |
| A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) (NCT07202546) | ViiV Healthcare | 2026-02-11 |
| Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) (NCT07432295) | I-Mab Biopharma US Limited | 2026-02-11 |
| A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors (NCT07466160) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2026-02-11 |
| Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer (NCT07379476) | Chinese University of Hong Kong | 2026-02-11 |
| Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors (NCT06625190) | University of Florida | 2026-02-11 |
| A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor (NCT07187401) | Regeneron Pharmaceuticals | 2026-02-11 |
| Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] (NCT07071961) | M.D. Anderson Cancer Center | 2026-02-11 |
| Thymosin-α1 for Recurrent Implantation Failure (NCT07675980) | Fakih IVF Fertility Center | 2026-02-11 |
| Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis (NCT06860542) | AHS Cancer Control Alberta | 2026-02-10 |
| Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy (NCT07496190) | Sun Yat-sen University | 2026-02-10 |
| Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib (NCT07396454) | The First Affiliated Hospital with Nanjing Medical University | 2026-02-10 |
| Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC) (NCT07413601) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-02-10 |
| Trial Evaluating Hypo-fractionated Accelerated Versus Conventional Fractionated Adjuvant RT in Head & Neck Malignancies (NCT07573956) | All India Institute of Medical Sciences | 2026-02-10 |
| Antibacterial Effect and Post-operative Pain Following Various Techniques of Intracanal Heating of NaOCL (NCT07420920) | Misr University for Science and Technology | 2026-02-10 |
| A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma (NCT07392320) | Sun Yat-sen University | 2026-02-10 |
| A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. (NCT07215702) | AstraZeneca | 2026-02-10 |
| Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma (NCT07416890) | Zhejiang Cancer Hospital | 2026-02-10 |
| Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL (NCT07457177) | LIANG WANG | 2026-02-10 |
| A Study of Brenipatide in Adult Participants With Schizophrenia (NCT07410507) | Eli Lilly and Company | 2026-02-10 |
| ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy (NCT07410611) | Hebei Medical University Fourth Hospital | 2026-02-10 |
| A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract (NCT07395986) | Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. | 2026-02-10 |
| Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer (NCT07458529) | Seventh Medical Center of PLA General Hospital | 2026-02-10 |
| SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China (NCT07387302) | Linno Pharmaceuticals, Inc. | 2026-02-10 |
| TIL Therapy in cSCC and MCC (NCT07288073) | Karam Khaddour, MD, MS | 2026-02-10 |
| Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis (NCT07335887) | Peking University People's Hospital | 2026-02-10 |
| Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance (NCT07285057) | Icahn School of Medicine at Mount Sinai | 2026-02-10 |
| Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin (NCT07699276) | Mahidol University | 2026-02-10 |
| Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD (NCT07418177) | The First Affiliated Hospital with Nanjing Medical University | 2026-02-10 |
| First-Time-in-Human Study of GSK5471713 in Adults With mCRPC (NCT07332455) | GlaxoSmithKline | 2026-02-10 |
| Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer (NCT07227415) | Pfizer | 2026-02-10 |
| Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. (NCT06059261) | Chongqing University Cancer Hospital | 2026-02-09 |
| The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia (NCT07362355) | Jiangsu HengRui Medicine Co., Ltd. | 2026-02-09 |
| RIG 101 Trial in Healthy Adults and Adults With Asthma (NCT07488897) | RIGImmune Inc. | 2026-02-09 |
| KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) (NCT07232602) | Merck Sharp & Dohme LLC | 2026-02-09 |
| Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. (NCT07410793) | Mae Fah Luang University | 2026-02-09 |
| Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) (NCT06999980) | Melanoma Institute Australia | 2026-02-09 |
| GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia (NCT07372885) | University of Manchester | 2026-02-09 |
| A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (NCT07266441) | Janssen Research & Development, LLC | 2026-02-08 |
| PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL. (NCT07410520) | The First Affiliated Hospital with Nanjing Medical University | 2026-02-07 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies (NCT07213830) | Ipsen | 2026-02-06 |
| A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients (NCT07352969) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-02-06 |
| T-cell Therapy in Patients With PML (NCT06990087) | Hannover Medical School | 2026-02-06 |
| "Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis" (NCT06915701) | University of Guadalajara | 2026-02-06 |
| A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus (NCT07340320) | Corxel Pharmaceuticals | 2026-02-06 |
| A Dose-exploration Study of EDP167 in HoFH (NCT07489209) | Eddingpharm (Zhuhai) Co., Ltd. | 2026-02-06 |
| Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia (NCT07365462) | Neurocrine Biosciences | 2026-02-06 |
| A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis (NCT07399067) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-02-06 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (NCT07304089) | Vima Therapeutics | 2026-02-05 |
| TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD (NCT07487363) | Hudson Biotech | 2026-02-05 |
| A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis (NCT07250750) | ImmunAbs Inc. | 2026-02-05 |
| A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer (NCT07253142) | Shanghai Henlius Biotech | 2026-02-05 |
| Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC (NCT07398937) | Fudan University | 2026-02-05 |
| A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine (NCT06721494) | Clear Scientific, Inc. | 2026-02-05 |
| A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. (NCT07375758) | Beijing Mabworks Biotech Co., Ltd. | 2026-02-05 |
| Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients (NCT07359261) | University of Alberta | 2026-02-05 |
| DNV001 Injection in Patients With Hypercholesterolemia (NCT07391722) | Hangzhou Dinovate Biotech Co., Ltd | 2026-02-05 |
| Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children. (NCT06968546) | Fondation Lenval | 2026-02-05 |
| A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors (NCT07287995) | Astellas Pharma Global Development, Inc. | 2026-02-05 |